Treatment
Treatment of hepatic encephalopathy is based on four simple principles:
Identification and Treatment or Precipitating Factors. lists several important factors that may precipitate or severely aggravate hepatic encephalopathy in patients with severe liver disease. Gastrointestinal bleeding and increased protein intake may provide increased substrate for the bacterial or metabolic formation of nitrogenous compounds that induce encephalopathy. In patients prone to develop hepatic encephalopathy there is a markedly increased sensitivity to central nervous system-depressant drugs, and their use should be avoided in these patients.
Reduction and Elimination of Substrate for the Generation or Nitrogenous Compounds, (a) Dietary protein restriction. Patients in coma should receive no protein, whereas those with mild encephalopathy may benefit from restriction of protein intake to 40 to 60 grams per day. Vegetable protein diets also appear to be less encephalopathogenic. (b) Bowel cleansing. This is important mainly in patients with encephalopathy precipitated by gastrointestinal bleeding or constipation, and is achieved by administration of enemas.
Reduction of Colonic Bacteria. Neomycin administered orally reduces the number of bacteria that are responsible for production of ammonia and other nitrogenous compounds.
Prevention of Ammonia Diffusion from the Bowel. This is achieved by administration of lactulose, a nonabsorbable disaccharide, which, when fermented to organic acids by colonic bacteria, leads to a lower stool pH. This lowered pH traps ammonia in the colon as nondiffusible NH4~ ions, but other mechanisms such as inhibition of bacterial ammonia production may also be important.
- NORMAL ABSORPTION
- Bartter’s Syndrome
- MYOCARDIAL METABOLISM
- The Fanconi Syndrome
- MEDIASTINITIS
- Laparoscopy
- CLINICAL FEATURES OF PULMONARY HYPERTENSION
- Membranoproliferative Glomerulonephritis (MPGN)
- MISCELLANEOUS AORTIC DISEASE
- Diagnosis
- CLINICAL CLASSIFICATION OF JAUNDICE
- ARRHYTHMIAS in ACUTE MYOCARDIAL MFARCTION
- Metabolism of Drugs in Patients with Renal Insufficiency
- POSTCAPILLARY PULMONARY HYPERTENSION
- Other Cystic Diseases
- Ascites
- HEMODIALYSIS AND HEMOPERFUSION IN THE TREATMENT OF DRUG OVERDOSES
- RISK FACTORS
- ACUTE RENAL INSUFFICIENCY
- NONRESPIRATORY FUNCTIONS OF THE LUNG
- Nephrosclerosis
- Community Acquired Pneumonia
- NONMEDICAL MANAGEMENT OF ANGINA PECTORIS
- Diagnosis
- SPECIFIC ENTITIES - DISEASES WITH KFiOWIi ETIOLOGIES -
- Ovarian Cancer
- Urolithiasis
- PULMOIIARY FUNCTION EVALUATION
- PHYSIOLOGY OF THE SYSTEMIC CIRCULATION
- DRUGS
- Important NEPHROTOXIRIS
- Miscellaneous
- Differential Diagnosis and Evaluation of the Patient
- Idiopathic Pulmonary Fibrosis
- CARCINOMA OF THE PANCREAS - Diagnosis